References
- Motwani M. Treatment of Keratoconus with WaveLight Contoura and Corneal Cross-Linking Combined. Clin Ophthalmol. 2021;15:2455–2472. doi:10.2147/OPTH.S303559
- Godfrey BM, Shuren AW. Understanding On-Label, Off-Label, and Unapproved Products. CRST; October, 2020. Available from: https://crstoday.com/articles/2020-oct/understanding-on-label-off-label-and-unapproved-products. Accessed June 16, 2021.
- U.S. Food and Drug Administration. “Off-Label” and Investigational Use of Marketed Drugs, Biologics, and Medical Devices Guidance for Institutional Review Boards and Clinical Investigators [Information Sheet]; 1998. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/label-and-investigational-use-marketed-drugs-biologics-and-medical-devices. Accessed June 16, 2021.